These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26016802)

  • 1. Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.
    Borgwardt L; Thuesen AM; Olsen KJ; Fogh J; Dali CI; Lund AM
    J Inherit Metab Dis; 2015 Nov; 38(6):1119-27. PubMed ID: 26016802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.
    Borgwardt L; Dali CI; Fogh J; Månsson JE; Olsen KJ; Beck HC; Nielsen KG; Nielsen LH; Olsen SO; Riise Stensland HM; Nilssen O; Wibrand F; Thuesen AM; Pearl T; Haugsted U; Saftig P; Blanz J; Jones SA; Tylki-Szymanska A; Guffon-Fouiloux N; Beck M; Lund AM
    J Inherit Metab Dis; 2013 Nov; 36(6):1015-24. PubMed ID: 23494656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: Report of seven new cases.
    Lehalle D; Colombo R; O'Grady M; Héron B; Houcinat N; Kuentz P; Moutton S; Sorlin A; Thevenon J; Delanne J; Gay S; Racine C; Garde A; Tran Mau-Them F; Philippe C; Vitobello A; Nambot S; Huet F; Duffourd Y; Feillet F; Thauvin-Robinet C; Marlin S; Faivre L
    Am J Med Genet A; 2019 Sep; 179(9):1756-1763. PubMed ID: 31241255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice.
    Stroobants S; Damme M; Van der Jeugd A; Vermaercke B; Andersson C; Fogh J; Saftig P; Blanz J; D'Hooge R
    Neurobiol Dis; 2017 Oct; 106():255-268. PubMed ID: 28720484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural characterisation of the alpha-mannosidosis guinea pig.
    Robinson AJ; Crawley AC; Auclair D; Weston PF; Hirte C; Hemsley KM; Hopwood JJ
    Behav Brain Res; 2008 Jan; 186(2):176-84. PubMed ID: 17889945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment.
    Borgwardt L; Lund AM; Dali CI
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():185-91. PubMed ID: 25345101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.
    Borgwardt L; Stensland HM; Olsen KJ; Wibrand F; Klenow HB; Beck M; Amraoui Y; Arash L; Fogh J; Nilssen Ø; Dali CI; Lund AM
    Orphanet J Rare Dis; 2015 Jun; 10():70. PubMed ID: 26048034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.
    Lund AM; Borgwardt L; Cattaneo F; Ardigò D; Geraci S; Gil-Campos M; De Meirleir L; Laroche C; Dolhem P; Cole D; Tylki-Szymanska A; Lopez-Rodriguez M; Guillén-Navarro E; Dali CI; Héron B; Fogh J; Muschol N; Phillips D; Van den Hout JMH; Jones SA; Amraoui Y; Harmatz P; Guffon N
    J Inherit Metab Dis; 2018 Nov; 41(6):1225-1233. PubMed ID: 29725868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audiological and radiological study of eight polish patients with alpha-mannosidosis.
    Iwanicka-Pronicka K; Guzek A; Sarnecki J; Tylki-Szymańska A
    Int J Pediatr Otorhinolaryngol; 2023 Jun; 169():111556. PubMed ID: 37099947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature.
    Hennermann JB; Raebel EM; Donà F; Jacquemont ML; Cefalo G; Ballabeni A; Malm D
    Orphanet J Rare Dis; 2022 Jul; 17(1):287. PubMed ID: 35871018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-mannosidosis.
    Malm D; Nilssen Ø
    Orphanet J Rare Dis; 2008 Jul; 3():21. PubMed ID: 18651971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
    Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
    Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis.
    Zielonka M; Garbade SF; Kölker S; Hoffmann GF; Ries M
    J Inherit Metab Dis; 2019 Sep; 42(5):975-983. PubMed ID: 31222755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of alpha mannosidosis a longitudinal study.
    Beck M; Olsen KJ; Wraith JE; Zeman J; Michalski JC; Saftig P; Fogh J; Malm D
    Orphanet J Rare Dis; 2013 Jun; 8():88. PubMed ID: 23786919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of alpha-mannosidosis in paediatric and adult patients: Presentation of a diagnostic algorithm from an international working group.
    Guffon N; Tylki-Szymanska A; Borgwardt L; Lund AM; Gil-Campos M; Parini R; Hennermann JB
    Mol Genet Metab; 2019 Apr; 126(4):470-474. PubMed ID: 30792122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of language and cognitive development in patients with mannosidosis.
    Noll RB; Kulkarni R; Netzloff ML
    Arch Neurol; 1986 Feb; 43(2):157-9. PubMed ID: 3947258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
    Damme M; Stroobants S; Walkley SU; Lüllmann-Rauch R; D'Hooge R; Fogh J; Saftig P; Lübke T; Blanz J
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):83-94. PubMed ID: 21157375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation.
    Grewal SS; Shapiro EG; Krivit W; Charnas L; Lockman LA; Delaney KA; Davies SM; Wenger DA; Rimell FL; Abel S; Grovas AC; Orchard PJ; Wagner JE; Peters C
    J Pediatr; 2004 May; 144(5):569-73. PubMed ID: 15126988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregivers' and Physicians' Perspectives on Alpha-Mannosidosis: A Report from Italy.
    Verrecchia E; Sicignano LL; Massaro MG; Rocco R; Silvestri G; Rossi S; Manna R
    Adv Ther; 2021 Jan; 38(1):1-10. PubMed ID: 33231860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional abilities and cognitive decline in adult and aging intellectual disabilities. Psychometric validation of an Italian version of the Alzheimer's Functional Assessment Tool (AFAST): analysis of its clinical significance with linear statistics and artificial neural networks.
    De Vreese LP; Gomiero T; Uberti M; De Bastiani E; Weger E; Mantesso U; Marangoni A
    J Intellect Disabil Res; 2015 Apr; 59(4):370-84. PubMed ID: 24397351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.